OCTREOTIDE FOR TREATMENT RECURRENT HYPOGLYCEMIA INDUCED BY SULFONYLUREA: A CASE REPORT AND LITERATURE REVIEW
Main Article Content
Overdose can cause hypoglycemia, which is unresponsive to dextrose treatment alone. Octreotide, though not universally used, is an antidote for sulfonylurea overdose. We present a case report of a 62-year-old male who mistakenly consumed six tablets of sulfonylurea (Glibenclamide®), thinking they were loperamide for diarrhea. He developed dizziness, diaphoresis, vomiting, and unconsciousness. Physical examination revealed a GCS of 225, blood pressure of 188/79 mmHg, heart rate of 85 bpm, respiratory rate of 24/min, and oxygen saturation of 99%. Blood results showed RBS at 13 mg/dl, normal CBC, unremarkable blood gas analysis, hypokalemia at 2.87 mmol/l, and normal RFT and LFT. The patient was treated with bolus Dextrose 40%, maintenance Dextrose 10%, and hydrocortisone 100 mg, but blood sugar remained refractory for 1 hour despite increasing glucose infusion. After 5 hours without satisfactory results, we administered the first dose of octreotide (50 IU IV), resulting in a hypoglycemic interval lasting 2.5 hours. After a second dose of 50 IU octreotide, hypoglycemia was resolved. The patient was moved to the general ward and survived. In this case, octreotide extended the interval of hypoglycemia and reduced the need for dextrose. Using octreotide for conditions other than sulfonylurea overdose is not recommended.
2. American Diabetes Association (2021). 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021. Diabetes care, 44(Suppl1),S111S124. https://doi.org/10.2337/dc21-S009
3. Braatvedt, G. D., Sykes, A. J., Panossian, Z., & McNeill, D. (2014). The clinical course of patients with type 2 diabetes presenting to the hospital with sulfonylurea-induced hypoglycemia. Diabetes technology & therapeutics, 16(10), 661–666. https://doi.org/10.1089/dia.2014.0024
4. Katzung BG. Basic & clinical pharmacology. 15th ed. New York: McGraw-Hill Education; 2021.
5. Klein-Schwartz W, Stassinos GL, IsbisterGK. Treatment of sulfonylurea and insulin overdose. Br J Clin Pharmacol 2016;81(3):496-504.
6. Howland E, & Smith S.W. (2019). Antidotes in depth. Nelson L.S., & Howland M, & Lewin N.A., & Smith S.W., & Goldfrank L.R., & Hoffman R.S.(Eds.), Goldfrank's Toxicologic Emergencies, 11e. McGraw-Hill Education. https://accesspharmacy.mhmedical.com/content.aspx?bookid=2569§ionid=210256656
7. Kamran, Khan., Sameed, Ullah, Qureshi. (2019). Inadvertent Sulfonylurea Overdose and Treatment withOctreotide: A Case Report.
8. Yamaguchi, S., Ikejima, M., Furukawa, A., Abe, M., Nakazaki, M., & Ishihara, H. (2015). Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor. Diabetes research and clinical practice, 109(2), e8–e10. https://doi.org/10.1016/j.diabres.2015.05.008
9. Akshay, Kothari., Kiran, Shah. (2021). Role of octreotide in management of sulphonylurea - induced refractory hypoglycemia : a case report. International journal of scientific research, doi: 10.36106/IJSR/9600245
10. S, M, Biradar., Arpitha, MaliPatil. (2019). Octreotide in Sulfonylurea Poisoning. International Journal of Research,
11. Patrick, P., Dougherty., Wendy, Klein-Schwartz. (2010). Octreotide's role in the management of sulfonylurea-induced hypoglycemia.. Journal of Medical Toxicology, doi: https://doi.org/10.1007/s13181-010-0064-z
12. Maryland Poison Center 2018, ToxTidbits: Antidote Facts, Accessed 2 February 2020, https://www.mdpoison.com/media/SOP/mdpoisoncom/healthcareprofessionals/antidoteacts/octreotide
13. Carr R, Zed PJ (2002) Octreotide for sulfonylurea-induced hypoglycemia following overdose. Ann Pharmacother 36:1727–1732. doi: https://doi.org/10.1345/aph.1C076
14. McLaughlin, S. A., Crandall, C. S., & McKinney, P. E. (2000). Octreotide: an antidote for sulfonylurea-induced hypoglycemia. Annals of emergency medicine, 36(2), 133–138. 3
